Safety, Handling & Reconstitution For optimal solubility and structural stability, researchers must reconstitute the lyophilised solid using Bacteriostatic Reconstitution Solution (0.9% Benzyl Alcohol)
The peptide BPC-157 has not been evaluated for safety as part of the drug review process of the United States Food and Drug Administration (FDA), nor has it been formally evaluated for safety by any international regulatory counterpart of the FDA
If the reconstituted solution is not dark red or if particulate matter is observed after the solution has been appropriately mixed, the solution should be discarded
Recognizing External Concerns and Self-Reflection: Awareness of AUD can arise through external concerns voiced by friends, family, or colleagues
Biogenic Foods is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act